Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -1.25 |
peg ratio | -0.29 |
price to book ratio | 1.50 |
price to sales ratio | 51.22 |
enterprise value multiple | -1.01 |
price fair value | 1.50 |
profitability ratios | |
---|---|
gross profit margin | 87.97% |
operating profit margin | -4037.43% |
pretax profit margin | -4109.41% |
net profit margin | -4109.41% |
return on assets | -66.92% |
return on equity | -107.38% |
return on capital employed | -74.06% |
liquidity ratio | |
---|---|
current ratio | 7.45 |
quick ratio | 7.43 |
cash ratio | 0.96 |
efficiency ratio | |
---|---|
days of inventory outstanding | 369.06 |
operating cycle | 571.14 |
days of payables outstanding | 8,240.64 |
cash conversion cycle | -7,669.50 |
receivables turnover | 1.81 |
payables turnover | 0.04 |
inventory turnover | 0.99 |
debt and solvency ratios | |
---|---|
debt ratio | 0.32 |
debt equity ratio | 0.57 |
long term debt to capitalization | 0.36 |
total debt to capitalization | 0.36 |
interest coverage | -12.32 |
cash flow to debt ratio | -2.05 |
cash flow ratios | |
---|---|
free cash flow per share | -0.58 |
cash per share | 0.71 |
operating cash flow per share | -0.57 |
free cash flow operating cash flow ratio | 1.00 |
cash flow coverage ratios | -2.05 |
short term coverage ratios | 0.00 |
capital expenditure coverage ratio | -373.14 |
Frequently Asked Questions
Lexicon Pharmaceuticals, Inc. (LXRX) published its most recent earnings results on 13-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)'s trailing twelve months ROE is -107.38%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Lexicon Pharmaceuticals, Inc. (LXRX) currently has a ROA of -66.92%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
LXRX reported a profit margin of -4109.41% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 7.45 in the most recent quarter. The quick ratio stood at 7.43, with a Debt/Eq ratio of 0.57.